O. Barbier et al., Cloning and characterization of a simian UDP-glucuronosyltransferase enzyme UGT2B20, a novel C-19 steroid-conjugating protein, BIOCHEM J, 337, 1999, pp. 567-574
Steroid glucuronidation by UDP-glucuronosyltransferase (UGT) enzymes is a m
echanism leading to catabolism and elimination of steroid hormones. To esta
blish an animal model to investigate the conjugation of steroids by UGT enz
ymes, previous results revealed that simian and human are unique in having
high levels of circulating androsterone glucuronide and androstane-3 alpha,
17 beta-diol (3d-Diol) glucuronide. A cDNA, UGT2B20, was isolated from cyno
molgus monkey liver and prostate libraries. The cDNA was 2075 bp in length
and contained an open reading frame of 1590 bp, encoding a protein of 530 a
mino acid residues. The UGT2B20 clone was transfected and stably expressed
in the human embryo kidney HK293 cell line, and the transferase activity of
UGT2B20 was tested with 73 compounds. This enzyme was shown to be active w
ith androgens, such as testosterone, dihydrotestosterone (DHT) and 3 alpha-
Diol, and on catecholoestrogens including 1,3,5,10-oestratriene-3,4-diol-17
-one. Kinetic analysis performed with intact cells yielded apparent K-m val
ues of 1.1, 2.3 and 4.6 mu M for 3 alpha-Diol, DHT and testosterone respect
ively. Reverse transcriptase-PCR analysis demonstrated that UGT2B20 transcr
ipt is expressed in several tissues including the liver, prostate, kidney,
epididymis and adrenal of the cynomolgus monkey. Amino acid sequence alignm
ent shows that the UGT2B20 protein is 92% identical with UGT2B15. Both enzy
mes have similar apparent K-m values for DHT and 3 alpha-Diol, and demonstr
ate similar transcript tissue distribution. The characterization of simian
UGT2B20 as a structural and functional homologue of human UGT2B15 further d
emonstrates the similarities of steroid glucuronidation in these two specie
s, and indicates the relevance of using the monkey as an animal model to st
udy and understand steroid glucuronidation in extrahepatic-steroid target t
issues.